White label ELPA - ClinicalTrials.eu

Study on Durvalumab and Platinum-Based Drug Combination for Patients with Stage IIB-IIIB Non-Small Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
+3
Study on the Safety and Effectiveness of Pembrolizumab and Drug Combination for Patients with Stage III Melanoma Eligible for Neoadjuvant Therapy

Not recruiting

1 1 1 1
Investigated diseases:
- Malignant melanoma
Investigated drugs:
Study on Durvalumab with Oleclumab or Monalizumab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy

Not recruiting

3 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
Study on Luspatercept for Patients with Lower-risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions

Not recruiting

3 1 1 1
Investigated drugs:
- Luspatercept
+1
Study Comparing Talquetamab, Pomalidomide, and Teclistamab for Patients with Relapsed or Refractory Myeloma After 1 to 4 Prior Treatments

Not recruiting

3 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
+7
Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma Not Well Controlled

Not recruiting

3 1 1
Investigated diseases:
- Asthma
Investigated drugs:
Study on Benralizumab and Mometasone Furoate for Patients with Severe Eosinophilic Chronic Rhinosinusitis with Nasal Polyps and Asthma

Not recruiting

3 1 1
Investigated diseases:
- Chronic rhinosinusitis with nasal polyps
Investigated drugs:
- Mometasone Furoate
- Benralizumab
Study on Long-Term Safety of Depemokimab for Adults and Adolescents with Severe Eosinophilic Asthma

Not recruiting

3 1 1
Investigated diseases:
- Asthma
Investigated drugs:
- Depemokimab
+1
Study on AON-D21 for Patients with Severe Community-Acquired Pneumonia in Intensive Care

Not recruiting

2 1
Investigated diseases:
- Pneumonia
Investigated drugs:
- Aon-D21
Study on Long-Term Safety of Soticlestat for Patients with Dravet or Lennox-Gastaut Syndromes

Not recruiting

3 1 1
Investigated drugs:
- Soticlestat
+4

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies